Skip to Content
주식/증권 ➡️ 중립

How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise

요약

The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.